ArticleClinical pharmacokinetics2019

Assessment of Drug-Drug Interactions between Taspoglutide, a Glucagon-Like Peptide-1 Agonist, and Drugs Commonly Used in Type 2 Diabetes Mellitus: Results of Five Phase I Trials.

Katrijn Bogman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.